- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic regulation of prostate cancer
Authors
Keywords
-
Journal
Clinical Epigenetics
Volume 2, Issue 2, Pages 151-169
Publisher
Springer Nature
Online
2011-06-13
DOI
10.1007/s13148-011-0041-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improvement of Prostate Cancer Detection by Integrating the PSA Test With miRNA Expression Profiling
- (2011) Yubin Hao et al. CANCER INVESTIGATION
- Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
- (2011) P. Ostling et al. CANCER RESEARCH
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening
- (2011) Sven Wach et al. INTERNATIONAL JOURNAL OF CANCER
- Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression
- (2011) Liyang Liu et al. INTERNATIONAL JOURNAL OF CANCER
- OPERating ON Chromatin, a Colorful Language where Context Matters
- (2011) Kathryn E. Gardner et al. JOURNAL OF MOLECULAR BIOLOGY
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- MicroRNAs and prostate cancer
- (2010) Y. Pang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy
- (2010) Michael Schnekenburger et al. BIOCHEMICAL PHARMACOLOGY
- Methylated genes as potential biomarkers in prostate cancer
- (2010) Veronique Phé et al. BJU INTERNATIONAL
- A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
- (2010) Dana Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pretreatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA)
- (2010) Hirak S. Basu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
- (2010) T. Bianco-Miotto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Feasibility of Therapy With Hypomethylating Agents in Patients With Renal Insufficiency
- (2010) G. Nicolas Batty et al. Clinical Lymphoma Myeloma & Leukemia
- MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β
- (2010) Paul Cao et al. Molecular Cancer
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of the androgen receptor by SET9-mediated methylation
- (2010) Luke Gaughan et al. NUCLEIC ACIDS RESEARCH
- Characterization of the Small RNA Transcriptomes of Androgen Dependent and Independent Prostate Cancer Cell Line by Deep Sequencing
- (2010) Gang Xu et al. PLoS One
- 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors
- (2010) Giovanni Luca Gravina et al. PROSTATE
- Percentage of Free Prostate-specific Antigen: Implications in Modern Extended Scheme Prostate Biopsy
- (2010) Byron H. Lee et al. UROLOGY
- Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
- (2009) L. R. Molife et al. ANNALS OF ONCOLOGY
- Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
- (2009) P N Munster et al. BRITISH JOURNAL OF CANCER
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- CpG islands - ‘A rough guide’
- (2009) Robert S. Illingworth et al. FEBS LETTERS
- An operational definition of epigenetics
- (2009) S. L. Berger et al. GENES & DEVELOPMENT
- Promoter Methylation in APC, RUNX3, and GSTP1 and Mortality in Prostate Cancer Patients
- (2009) Lorenzo Richiardi et al. JOURNAL OF CLINICAL ONCOLOGY
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Global Demethylation of Rat Chondrosarcoma Cells after Treatment with 5-Aza-2′-Deoxycytidine Results in Increased Tumorigenicity
- (2009) Christopher A. Hamm et al. PLoS One
- Global levels of histone modifications predict prostate cancer recurrence
- (2009) Jörg Ellinger et al. PROSTATE
- Diagnostic Role of Circulating Free Plasma DNA Detection in Patients With Localized Prostate Cancer
- (2008) Annalisa Altimari et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
- (2008) Yasunori Fujita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity
- (2008) Jörg Ellinger et al. CANCER LETTERS
- Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells
- (2008) Mareike Schmudde et al. CANCER LETTERS
- DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity
- (2008) Srinivasan Yegnasubramanian et al. CANCER RESEARCH
- Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
- (2008) S. Ambs et al. CANCER RESEARCH
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
- (2008) Neri Mercatelli et al. PLoS One
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
- CpG Island Hypermethylation at Multiple Gene Sites in Diagnosis and Prognosis of Prostate Cancer
- (2008) Jörg Ellinger et al. UROLOGY
- Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts
- (2007) Lalji K. Gediya et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
- (2007) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
- Depsipeptide (FK228) inhibits growth of human prostate cancer cells
- (2007) Ming-Tsung Lai et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation